N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-244X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms ; volume:16 ; number:1 ; day:15 ; month:9 ; year:2016 ; pages:1-9 ; date:12.2016
BMC psychiatry ; 16, Heft 1 (15.9.2016), 1-9, 12.2016

Creator: Rossell, Susan L.

Contributor: Francis, Paul S.
Galletly, Cherrie
Harris, Anthony
Siskind, Dan
Berk, Michael
Bozaoglu, Kiymet
Dark, Frances
Dean, Olivia
Liu, Dennis
Meyer, Denny
Neill, Erica
Phillipou, Andrea
Sarris, Jerome
Castle, David J.
SpringerLink (Online service)

DOI: 10.1186/s12888-016-1030-3

URN: urn:nbn:de:1111-201610163144

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rossell, Susan L.
Francis, Paul S.
Galletly, Cherrie
Harris, Anthony
Siskind, Dan
Berk, Michael
Bozaoglu, Kiymet
Dark, Frances
Dean, Olivia
Liu, Dennis
Meyer, Denny
Neill, Erica
Phillipou, Andrea
Sarris, Jerome
Castle, David J.
SpringerLink (Online service)

Other Objects (12)

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

The DSM-5: Hyperbole, Hope or Hypothesis?

Pathways to new drug discovery in neuropsychiatry

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

The DSM-5: Hyperbole, Hope or Hypothesis?

Pathways to new drug discovery in neuropsychiatry

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

The DSM-5: Hyperbole, Hope or Hypothesis?

Pathways to new drug discovery in neuropsychiatry

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

The DSM-5: Hyperbole, Hope or Hypothesis?

Pathways to new drug discovery in neuropsychiatry

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

The DSM-5: Hyperbole, Hope or Hypothesis?

Pathways to new drug discovery in neuropsychiatry

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial

The DSM-5: Hyperbole, Hope or Hypothesis?

Pathways to new drug discovery in neuropsychiatry

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

Protective role of N-acetylcysteine (NAC) on human sperm exposed to etoposide

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

Correction to: The Potential of N‑Acetyl‑L‑Cysteine (NAC) in the Treatment of Psychiatric Disorders

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: a study protocol

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

Related objects

Reset password